PTC Therapeutics, Inc. (PTCT) financial statements (2022 and earlier)

Company profile

Business Address 100 CORPORATE COURT
SOUTH PLAINFIELD, NJ 07080-2449
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7731,104687228191232339
Cash and cash equivalents1902092881691125858
Short-term investments5848953995879173281
Receivables110705668402511
Inventory, net of allowances, customer advances and progress billings16191916112 
Inventory16191916112 
Other undisclosed current assets5539189736
Total current assets:9541,232779321249261356
Noncurrent Assets
Operating lease, right-of-use asset778414
Property, plant and equipment53342213879
Intangible assets, net (including goodwill)807798793783133  
Goodwill82828282   
Intangible assets, net (excluding goodwill)725715711701133  
Regulated entity, other noncurrent assets      3
Other undisclosed noncurrent assets4761162110
Total noncurrent assets:984977844798143812
TOTAL ASSETS:1,9382,2081,6241,119392269368
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:289242159128764945
Accounts payable231910615612
Accrued liabilities52301322448
Employee-related liabilities56533928181411
Taxes payable14     
Other undisclosed accounts payable and accrued liabilities1571369773392514
Deferred revenue 48
Debt15312512   
Deferred revenue and credits4 0
Contract with customer, liability4
Other liabilities118421 
Other undisclosed current liabilities67283519   
Total current liabilities:509277236167825045
Noncurrent Liabilities
Long-term debt and lease obligation3764122941411459895
Long-term debt, excluding current maturities2823092941411459895
Finance lease, liability2023 
Operating lease, liability7479 
Liabilities, other than long-term debt377379500442822
Deferred revenue and credits82 
Deferred revenue  3
Contract with customer, liability10
Deferred tax liabilities, net122   
Deferred income tax liabilities137137131
Other liabilities 190002
Business combination, contingent consideration, liability240240356310   
Other undisclosed noncurrent liabilities675659 18   
Total noncurrent liabilities:1,4271,44979460215310097
Total liabilities:1,9371,7261,029768235150142
Stockholders' equity
Stockholders' equity attributable to parent1482594351156120226
Common stock0000000
Additional paid in capital2,1242,1721,7951,288967856820
Accumulated other comprehensive income (loss)(24)(61)(11)14(1)(1)
Accumulated deficit(2,098)(1,629)(1,190)(939)(814)(735)(593)
Total stockholders' equity:1482594351156120226
TOTAL LIABILITIES AND EQUITY:1,9382,2081,6241,119392269368

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues5393813072651948337
Revenue, net1948337
Cost of revenue
(Cost of Goods and Services Sold)
(2)(1)(12)(2)(5)  
Gross profit:5363802952631908337
Operating expenses(913)(813)(548)(380)(259)(215)(204)
Other undisclosed operating income211225  
Operating loss:(374)(432)(241)(116)(64)(132)(167)
Nonoperating income (expense)(58)142250(1)(1)(0)
Foreign currency transaction gain, before tax 571200  
Other nonoperating income (expense)(58)85140(1)(1)(0)
Interest and debt expense (1)(1)(1)(0)(0)(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes (112)(23)(12)(12)  
Loss from continuing operations before equity method investments, income taxes:(432)(403)(240)(128)(78)(134)(168)
Other undisclosed loss from continuing operations before income taxes(86)    (8)(2)
Loss from continuing operations before income taxes:(518)(403)(240)(128)(78)(142)(170)
Income tax expense (benefit)(6)(35)(12)0(1)(1)(0)
Net loss available to common stockholders, diluted:(524)(438)(252)(128)(79)(142)(170)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(524)(438)(252)(128)(79)(142)(170)
Other comprehensive income (loss)  (12)(3)5 (0)
Comprehensive loss:(524)(438)(264)(131)(74)(142)(171)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent37(50)   (0) 
Comprehensive loss, net of tax, attributable to parent:(487)(489)(264)(131)(74)(142)(171)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: